BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31197079)

  • 1. Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis.
    Ueland T; Stilgren L; Bollerslev J
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.
    Lim Y; Kim CH; Lee SY; Kim H; Ahn SH; Lee SH; Koh JM; Rhee Y; Baek KH; Min YK; Kim DY; Kim BJ; Kang MI
    Calcif Tissue Int; 2016 Oct; 99(4):350-9. PubMed ID: 27289555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis.
    Peng J; Dong Z; Hui Z; Aifei W; Lianfu D; Youjia X
    BMC Musculoskelet Disord; 2021 May; 22(1):480. PubMed ID: 34034718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic Analyses of the Sclerostin rs851056 and Dickkopf rs1569198 Polymorphisms in Mexican-Mestizo Postmenopausal Osteoporosis: A Case-Control Study.
    Vazquez-Villegas ML; Rodriguez-Jimenez NA; Contreras-Haro B; Vasquez-Jimenez JC; Perez-Guerrero EE; Moran-Moguel MC; Sánchez-Rodríguez EN; Villagómez-Vega A; Nuño-Arana I; Becerra-Alvarado IN; Rubio-Arellano ED; Nava-Valdivia CA; Ponce-Guarneros JM; Fajardo-Robledo NS; Nava-Zavala AH; Gonzalez-Lopez L; Saldaña-Cruz AM
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):211-217. PubMed ID: 33734895
    [No Abstract]   [Full Text] [Related]  

  • 6. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.
    Gatti D; Viapiana O; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Adami S; Rossini M
    J Bone Miner Res; 2012 Nov; 27(11):2259-63. PubMed ID: 22692843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms in sclerostin, dickkopfs and secreted frizzled-related protein genes and bone mineral density in postmenopausal Korean women.
    Lee DO; Kim H; Ku SY; Kim SH; Kim JG
    Gynecol Obstet Invest; 2014; 77(3):186-93. PubMed ID: 24662300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
    Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
    Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women.
    Velázquez-Cruz R; Jiménez-Ortega RF; Parra-Torres AY; Castillejos-López M; Patiño N; Quiterio M; Villarreal-Molina T; Salmerón J
    BMC Musculoskelet Disord; 2014 Nov; 15():400. PubMed ID: 25430630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
    Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
    Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
    Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.
    Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of sclerostin and secreted frizzled protein polymorphisms with bone mineral density: an association study with replication in postmenopausal women.
    Valero C; Zarrabeitia MT; Hernández JL; Pineda B; Cano A; García-Pérez MA; Riancho JA
    Menopause; 2011 Jul; 18(7):802-7. PubMed ID: 21441835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
    Choi HY; Dieckmann M; Herz J; Niemeier A
    PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.
    Rossini M; Viapiana O; Zanotti R; Tripi G; Perbellini O; Idolazzi L; Bonifacio M; Adami S; Gatti D
    Calcif Tissue Int; 2015 May; 96(5):410-6. PubMed ID: 25694360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
    He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study.
    Ueland T; Brixen K; Mosekilde L; Mosekilde L; Flyvbjerg A; Bollerslev J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1014-8. PubMed ID: 12629078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.
    Kashii M; Matuso Y; Sugiura T; Fujimori T; Nagamoto Y; Makino T; Kaito T; Ebina K; Iwasaki M; Yoshikawa H
    J Bone Miner Metab; 2016 May; 34(3):315-24. PubMed ID: 26040409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.